CN104918944B - 螺环异噁唑啉衍生物的合成 - Google Patents

螺环异噁唑啉衍生物的合成 Download PDF

Info

Publication number
CN104918944B
CN104918944B CN201380060755.4A CN201380060755A CN104918944B CN 104918944 B CN104918944 B CN 104918944B CN 201380060755 A CN201380060755 A CN 201380060755A CN 104918944 B CN104918944 B CN 104918944B
Authority
CN
China
Prior art keywords
formula
compound
alkyl
group
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380060755.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN104918944A (zh
Inventor
S·D·W·格林伍德
T·L·什图克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Services LLC
Original Assignee
Zoetis Services LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services LLC filed Critical Zoetis Services LLC
Publication of CN104918944A publication Critical patent/CN104918944A/zh
Application granted granted Critical
Publication of CN104918944B publication Critical patent/CN104918944B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201380060755.4A 2012-11-21 2013-11-20 螺环异噁唑啉衍生物的合成 Active CN104918944B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261729022P 2012-11-21 2012-11-21
US61/729,022 2012-11-21
PCT/US2013/070959 WO2014081800A1 (en) 2012-11-21 2013-11-20 Synthesis of spirocyclic isoxazoline derivatives

Publications (2)

Publication Number Publication Date
CN104918944A CN104918944A (zh) 2015-09-16
CN104918944B true CN104918944B (zh) 2017-05-10

Family

ID=49753486

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380060755.4A Active CN104918944B (zh) 2012-11-21 2013-11-20 螺环异噁唑啉衍生物的合成

Country Status (11)

Country Link
US (1) US9593126B2 (enExample)
EP (2) EP2922854B1 (enExample)
JP (1) JP6234471B2 (enExample)
CN (1) CN104918944B (enExample)
AU (1) AU2013348091B2 (enExample)
BR (1) BR112015011740B1 (enExample)
CA (1) CA2892344C (enExample)
ES (1) ES2916805T3 (enExample)
MX (1) MX368078B (enExample)
PL (1) PL2922854T3 (enExample)
WO (1) WO2014081800A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014039489A1 (en) * 2012-09-07 2014-03-13 Zoetis Llc Spirocyclic derivatives as antiparasitic agents
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
EP3426660A1 (en) 2016-03-09 2019-01-16 Basf Se Spirocyclic derivatives
MY189534A (en) 2016-04-06 2022-02-16 Merial Inc Process for the preparation of isoxazoline compounds
WO2017201134A1 (en) * 2016-05-20 2017-11-23 Avista Pharma Solutions, Inc. Synthetic process and novel intermediates
JP2019535655A (ja) 2016-10-14 2019-12-12 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 殺虫性及び殺寄生虫性ビニルイソオキサゾリン化合物
WO2018162312A1 (en) * 2017-03-10 2018-09-13 Basf Se Spirocyclic derivatives
MX2020001724A (es) 2017-08-14 2020-07-29 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas.
CA3118033A1 (en) * 2018-11-06 2020-05-14 Basf Se Process for preparation of optically enriched isoxazolines
US12655138B2 (en) 2020-07-24 2026-06-16 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
CN113548989A (zh) * 2021-07-14 2021-10-26 浙江倍合德制药有限公司 一种4-硝基苯基-2-甲磺酰基乙酸酯的制备工艺及其生产线
CA3224701A1 (en) 2021-08-11 2023-02-16 Jingdan Hu Process for making diaryl isoxazoline derivative
WO2026043852A1 (en) 2024-08-20 2026-02-26 Zoetis Services Llc Process for preparing optically enriched isoxazolines

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012120399A1 (en) * 2011-03-10 2012-09-13 Pfizer Inc. Spirocyclic isoxazoline derivatives as antiparasitic agents
WO2012151158A1 (en) * 2011-04-30 2012-11-08 Abbott Laboratories Isoxazolines as therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
AU2004249495A1 (en) * 2003-06-20 2004-12-29 Ucb Pharma S.A. Thienopyridone derivatives as kinase inhibitors
ES2682303T3 (es) * 2010-08-05 2018-09-19 Zoetis Services Llc Derivados de isoxazolina como agentes antiparasitarios
US9167013B2 (en) * 2011-03-10 2015-10-20 Telefonaktiebolaget L M Ericsson (Publ) Method and apparatus for prioritizing media within an electronic conference according to utilization settings at respective conference participants
TWM424868U (en) 2011-09-02 2012-03-21 yi-zhen Huang Baby walker

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012120399A1 (en) * 2011-03-10 2012-09-13 Pfizer Inc. Spirocyclic isoxazoline derivatives as antiparasitic agents
WO2012151158A1 (en) * 2011-04-30 2012-11-08 Abbott Laboratories Isoxazolines as therapeutic agents

Also Published As

Publication number Publication date
CA2892344A1 (en) 2014-05-30
EP2922854B1 (en) 2022-05-04
CA2892344C (en) 2017-06-06
CN104918944A (zh) 2015-09-16
AU2013348091A8 (en) 2015-07-09
EP4056572A1 (en) 2022-09-14
AU2013348091A1 (en) 2015-06-04
BR112015011740A2 (pt) 2017-07-11
ES2916805T3 (es) 2022-07-06
EP2922854A1 (en) 2015-09-30
AU2013348091B2 (en) 2017-04-13
JP2016500106A (ja) 2016-01-07
US9593126B2 (en) 2017-03-14
JP6234471B2 (ja) 2017-11-22
WO2014081800A1 (en) 2014-05-30
MX2015006458A (es) 2015-08-14
BR112015011740B1 (pt) 2020-04-14
PL2922854T3 (pl) 2022-07-18
MX368078B (es) 2019-09-17
US20150291612A1 (en) 2015-10-15

Similar Documents

Publication Publication Date Title
CN104918944A (zh) 螺环异噁唑啉衍生物的合成
TWI760919B (zh) 一種嘧啶並環衍生物及其在醫藥上的應用
CN111386276B (zh) 制备取代的多环吡啶酮衍生物的立体选择性方法
CA2577525C (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
CN112585126B (zh) 四环化合物的制备方法
CN107522698A (zh) 一种曲贝替定的制备方法及其中间体
BR112019017915A2 (pt) Processos para a preparação de compostos fungicidas
US20230278960A1 (en) Novel acridinium salt and method for producing same
CN104837817B (zh) 制备3‑氨基‑哌啶化合物的合成路线
EP4662326A1 (en) Ligand-enabled transannular c-h functionalization of cycloalkane carboxylic acids
CN103153947B (zh) 非对映选择性制备双环[2.2.2]辛-2-酮化合物
CN103709101A (zh) 一类renierramycin G的合成中间体及其制备方法
HK1213547B (en) Synthesis of spirocyclic isoxazoline derivatives
JP2016519669A (ja) ジフルオロラクタムアナログを合成する方法
CN103328471A (zh) 制备氮杂吲唑衍生物的方法
JP7587862B2 (ja) Ｌ－エリトロ－ビオプテリン類化合物の製造方法
CN119490501A (zh) 咪唑双环化合物及其制备方法和用途
RU2346947C1 (ru) Способ получения фурилгетарилметанов, содержащих тиено[2,3-b]пиридиновый фрагмент
HK40051429B (en) Method of producing tetracyclic compound
KR20170080190A (ko) 1,5-쌍극자의 [5+3] 고리화 첨가 반응을 이용한 8원 헤테로 고리 화합물의 제조 방법 및 이에 의해 제조된 8원 헤테로 고리 화합물
HK40051429A (en) Method of producing tetracyclic compound
Kovganko et al. Synthesis of Substituted Benzyl Ethers of 1-(4-Hydroxyphenyl) oct-2-en-1-one
WO2014133416A2 (ru) Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения
BR112018003171B1 (pt) Compostos de tetrahidrooxepinopiridina, composição farmacêutica compreendendo os ditos compostos e uso terapêutico dos mesmos
HK40028700B (en) Method for stereoselectively producing substituted polycyclic pyridone derivative

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant